Related Experiment Video
Updated: Jun 17, 2025

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies
Yu-Qing Tan1, Wang Zhang2, Zi-Cong Xie1
1Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Insights
Calcium/calmodulin-dependent kinase II (CaMK II) is crucial in cardiovascular diseases (CVDs). Targeting CaMK II isoforms may offer new therapeutic strategies for complex heart conditions.
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases (CVDs) present a significant societal and economic challenge, often affecting younger populations.
- The underlying physiological and pathological mechanisms of CVDs are intricate and not fully understood.
- Calcium/calmodulin-dependent kinase II (CaMK II) is a key protein kinase implicated in various biological functions and pathological processes.
Purpose of the Study:
- To analyze the structural characteristics and distribution of CaMK II.
- To elucidate the mechanism of action of CaMK II in cardiovascular health and disease.
- To explore the multifaceted relationship between CaMK II and various CVDs.
Main Methods:
- Literature review and analysis of existing research on CaMK II.
- Examination of CaMK II's role in ion channel function.
- Investigation of CaMK II's involvement in ischemia-reperfusion injury, arrhythmias, myocardial hypertrophy, cardiotoxicity, hypertension, and dilated cardiomyopathy.
Main Results:
- CaMK II plays a central role in the pathogenesis of numerous cardiovascular conditions.
- The protein kinase influences diverse cardiovascular processes, including electrical signaling and structural remodeling.
- Different isoforms of CaMK II exhibit distinct regulatory mechanisms.
Conclusions:
- CaMK II is a critical mediator in the development and progression of cardiovascular diseases.
- Understanding CaMK II's specific roles and isoform regulation is essential for therapeutic development.
- Future research should focus on targeted inhibitors and novel compounds for CaMK II to establish new treatment directions for CVDs.
Abstract:
Cardiovascular diseases (CVDs) tend to affect the young population and are associated with a significant economic burden and psychological distress to the society and families. The physiological and pathological processes underlying CVDs are complex. Ca2+/calmodulin-dependent kinase II (CaMK II), a protein kinase, has multiple biological functions. It participates in multiple pathological processes and plays a central role in the development of CVDs. Based on this, this paper analyzes the structural characteristics and distribution of CaMK II, the mechanism of action of CaMK II, and the relationship between CaMK II and CVDs, including ion channels, ischemia-reperfusion injury, arrhythmias, myocardial hypertrophy, cardiotoxicity, hypertension, and dilated cardiomyopathy. Given the different regulatory mechanisms of different isoforms of CaMK II, the clinical use of specific targeted inhibitors or novel compounds should be evaluated in future research to provide new directions.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers
cAMP-dependent Protein Kinase Pathways
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

